Bio-Works Technologies AB New Share Issue Fully Subscribed

Bio-Works Technologies AB is pleased to announce that its recent new share issue has been fully subscribed. Vator Securities in Stockholm advised and managed the funding round.
“We appreciate the renewed support of our existing investors and welcome new investors. This capital funding round will allow the Bio-Works team to accelerate commercialization and sales growth of its core agarose separation media products in Life Science and Food & Beverage sectors. Simply put, we will focus on doing more of what works”, says Mikael Gordon, chairman of the board Bio-Works. “We have had very good product performance with excellent customer feed-back in target markets with high growth potential, and with the recent Vinnova grant for the development of our bio-based emulsion production process we are in a strong position to grow rapidly” add Kris Fain, CEO.

For more information, please contact

Kris Fain, CEO Bio-Works Technologies AB
Mobile: +46 735 18 90 80

Share this post: